Sleep Medicine Update 2025
Description
Sleep medicine is evolving rapidly, with the year 2025 marking a pivotal phase in our understanding of sleep-disordered breathing, hypersomnolence disorders, and their long-term health consequences. Sleep Medicine Update 2025 has been carefully designed to bridge the gap between foundational concepts and the most important scientific publications published during 2025, translating cutting-edge evidence into practical clinical insight.
This computer-based, self-paced course brings together key advances in obstructive sleep apnea (OSA), including updated severity classifications, novel physiological and outcome-based metrics, patient selection for PAP therapy, cardiovascular risk modification, and long-term surgical outcomes. In addition, the course provides an in-depth, literature-driven update on narcolepsy and idiopathic hypersomnia, incorporating new epidemiological data, updated ICSD-3-TR diagnostic criteria, comorbidity burden, and emerging pharmacological therapies, all grounded in recent peer-reviewed research from 2025
Developed and directed by Dr. Tripat Deep Singh under the Academy of Sleep Wake Science, this program is particularly relevant for clinicians, sleep technologists, and RPSGT/CCSH credential holders seeking to stay current with evidence-based practice while earning 8 BRPT-approved CSTE points. Each module emphasizes critical appraisal of contemporary studies, clinical applicability, and evolving paradigms beyond traditional AHI-centric thinking.
Whether you are refreshing core concepts or seeking a structured synthesis of the most impactful sleep medicine literature of 2025, this course offers a comprehensive, clinically meaningful update to support modern sleep practice.
Topics for this course
Pre Test
Sleep Medicine Update 2025 Pre Test Quiz
New severity classification for OSA
Are we choosing OSA patients correctly for PAP therapy?
New metrics for assessing consequences of untreated OSA
is CPAP alone sufficient to reduce CVD risk?
How to treat persistent sleepiness in OSA patient after starting CPAP therapy?
Long term outcomes of surgical treatment of OSA
OSA phenotypes- POSA and REM OSA
Burden of narcolepsy in Asian patients and new ICSD-3-TR criteria for diagnosing Narcolepsy
Does Narcolepsy affect the healthcare, socioeconomic status and quality of life of patients?
What are the comorbidities and long term risks in Narcolepsy patients
New drugs for treating Narcolepsy
Should we treat patients with Idiopathic Hypersomnia?
Post Test
very good
Enrolment validity: 400 days